Page last updated: 2024-10-30

mesalamine and Sepsis

mesalamine has been researched along with Sepsis in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaye, TL1
O'Connor, A1
Burke, D1
Tolan, DJ1

Reviews

1 review available for mesalamine and Sepsis

ArticleYear
A young woman with recurrent perianal sepsis.
    BMJ (Clinical research ed.), 2015, Apr-23, Volume: 350

    Topics: Abscess; Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drainage; Female; Humans; Ma

2015